📰 Nasdaq Prtk News
Page 2 - Nasdaq Prtk News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Prtk. Real-time updates on events, politics, business and more.
June 26, 2023
StockNews.com started coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. A number of other equities analysts have also recently weighed in on the stock. HC Wainwright cut shares of Paratek Pharmaceuticals from […]
June 11, 2023
HC Wainwright lowered shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a neutral rating in a research note released on Wednesday morning, The Fly reports. Several other equities analysts have also recently commented on the stock. BTIG Research decreased their price target on shares of Paratek Pharmaceuticals from $24.00 to […]
June 9, 2023
StockNews.com upgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a hold rating to a buy rating in a report issued on Tuesday. A number of other research firms have also weighed in on PRTK. BTIG Research cut their price objective on shares of Paratek Pharmaceuticals from $24.00 to $5.00 in a research note […]
June 9, 2023
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was downgraded by HC Wainwright from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, The Fly reports. Several other research analysts have also weighed in on PRTK. StockNews.com raised Paratek Pharmaceuticals from a “hold” rating to a “buy” rating in a research […]
June 8, 2023
HC Wainwright downgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a neutral rating in a report issued on Wednesday, The Fly reports. Several other research firms also recently commented on PRTK. Jefferies Financial Group downgraded shares of Paratek Pharmaceuticals from a buy rating to a hold rating in a […]
June 7, 2023
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Tuesday. Several other equities research analysts have also recently issued reports on PRTK. BTIG Research cut their target price on Paratek Pharmaceuticals from $24.00 to $5.00 in a research note […]
May 24, 2023
StockNews.com downgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a report issued on Saturday. Other equities research analysts have also recently issued reports about the company. HC Wainwright lowered their target price on Paratek Pharmaceuticals from $10.00 to $6.00 in a research note on Wednesday, […]
May 21, 2023
StockNews.com lowered shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a research report sent to investors on Saturday. Several other equities research analysts also recently commented on PRTK. BTIG Research decreased their price objective on Paratek Pharmaceuticals from $24.00 to $5.00 in a report on Tuesday, […]
May 14, 2023
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) had its price objective cut by HC Wainwright from $10.00 to $6.00 in a research note published on Wednesday, The Fly reports. HC Wainwright also issued estimates for Paratek Pharmaceuticals’ Q2 2023 earnings at ($0.30) EPS, Q3 2023 earnings at ($0.24) EPS, Q4 2023 earnings at ($0.19) EPS, FY2023 […]
May 13, 2023
Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Friday. A number of other equities research analysts have also recently commented on PRTK. HC Wainwright dropped their price objective on shares of Paratek […]